Orexigen Therapeutics Receives $165,000,000 New Funding

  • Feed Type
  • Date
  • Company Name
    Orexigen Therapeutics
  • Mailing Address
    3344 N. Torrey Pines Court La Jolla, CA 92037 USA
  • Company Description
    OREXIGEN is studying a novel, and potentially more effective way, to achieve and sustain weight loss through a combined, two-drug approach.
  • Website
  • Transaction Type
    Venture Equity, Debt
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 21 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy